IBOV 168,498.45 ▲ 1.39% IPC MEX 71,393.57 ▲ 0.43% MERVAL 2,848,945 — — USD/BRL5.50▼ 0.19% USD/MXN18.61▼ 0.10% USD/CLP975.74▼ 0.09% USD/COP 3,240 — 0.00% USD/PEN3.44▼ 0.07% USD/ARS 1,545 — 0.00% USD/UYU40.31▲ 3.23% USD/PYG6,358▲ 6.40% USD/BOB11.81▲ 0.77% USD/DOP60.61▲ 4.08% USD/CRC448.27▲ 2.01% USD/GTQ7.64▲ 3.17% USD/HNL26.88▲ 3.19% USD/NIO 36.62 — 0.00% USD/VES895.29▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.99▲ 2.78% USD/TTD6.72▲ 2.44% EUR/BRL6.13▼ 0.68% BRENT 98.32 ▲ 0.03% WTI 90.83 ▲ 0.34% IRON ORE 161.91 — — COPPER 6.24 ▼ 0.18% GOLD 4,075 ▼ 0.94% SILVER 51.94 ▼ 0.56% SOY 1,194 ▲ 1.08% CORN 441.50 ▲ 0.34% WHEAT 591.25 ▼ 1.34% COFFEE 280.15 ▲ 1.08% SUGAR 18.25 ▼ 1.67% ORANGE JUICE 130.55 ▲ 1.63% COTTON 78.54 ▼ 0.22% COCOA 5,119 ▼ 1.20% BEEF 214.05 ▼ 0.16% CATTLE 318.38 ▼ 2.05% LITHIUM 60.91 ▲ 1.21% PETR4 45.36 — 0.00% VALE3 64.04 — 0.00% ITUB4 40.53 — 0.00% BBDC4 14.20 — 0.00% ABEV3 15.48 — 0.00% BBAS3 17.13 — 0.00% B3SA3 14.39 — 0.00% WEGE3 48.19 — 0.00% PRIO3 60.48 — 0.00% SUZB3 53.40 ▲ 2.12% RENT3 30.29 — 0.00% AZZA3 14.76 ▲ 4.98% CSAN3 2.77 — 0.00% RAIZ4 28.00 ▲ 2.56% PCAR3 2.40 ▲ 0.42% GMAT3 3.80 — 0.00% PSSA3 44.35 ▲ 1.46% CVCB3 0.84 ▲ 2.44% POSI3 3.09 ▼ 0.64% SLCE3 16.61 ▲ 1.59% NATU3 5.17 — 0.00% BRKM5 3.20 — 0.00% RANI3 8.53 ▲ 0.83% CSNA3 4.41 — 0.00% IBOV 168,498.45 ▲ 1.39% IPC MEX 71,393.57 ▲ 0.43% MERVAL 2,848,945 — — USD/BRL 5.50 ▼ 0.19% USD/MXN 18.61 ▼ 0.09% USD/CLP 975.74 ▼ 0.09% USD/COP 3,240 — 0.00% USD/PEN 3.44 ▼ 0.07% USD/ARS 1,545 — 0.00% USD/UYU 40.31 ▲ 3.23% USD/PYG 6,358 ▲ 6.40% USD/BOB 11.81 ▲ 0.77% USD/DOP 60.61 ▲ 4.08% USD/CRC 448.27 ▲ 2.01% USD/GTQ 7.64 ▲ 3.17% USD/HNL 26.88 ▲ 3.19% USD/NIO 36.62 — 0.00% USD/VES 895.29 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.99 ▲ 2.78% USD/TTD 6.72 ▲ 2.44% EUR/BRL 6.13 ▼ 0.69% BRENT 98.32 ▲ 0.03% WTI 90.83 ▲ 0.34% IRON ORE 161.91 — — COPPER 6.24 ▼ 0.18% GOLD 4,075 ▼ 0.94% SILVER 51.94 ▼ 0.56% SOY 1,194 ▲ 1.08% CORN 441.50 ▲ 0.34% WHEAT 591.25 ▼ 1.34% COFFEE 280.15 ▲ 1.08% SUGAR 18.25 ▼ 1.67% ORANGE JUICE 130.55 ▲ 1.63% COTTON 78.54 ▼ 0.22% COCOA 5,119 ▼ 1.20% BEEF 214.05 ▼ 0.16% CATTLE 318.38 ▼ 2.05% LITHIUM 60.91 ▲ 1.21% PETR4 45.36 — 0.00% VALE3 64.04 — 0.00% ITUB4 40.53 — 0.00% BBDC4 14.20 — 0.00% ABEV3 15.48 — 0.00% BBAS3 17.13 — 0.00% B3SA3 14.39 — 0.00% WEGE3 48.19 — 0.00% PRIO3 60.48 — 0.00% SUZB3 53.40 ▲ 2.12% RENT3 30.29 — 0.00% AZZA3 14.76 ▲ 4.98% CSAN3 2.77 — 0.00% RAIZ4 28.00 ▲ 2.56% PCAR3 2.40 ▲ 0.42% GMAT3 3.80 — 0.00% PSSA3 44.35 ▲ 1.46% CVCB3 0.84 ▲ 2.44% POSI3 3.09 ▼ 0.64% SLCE3 16.61 ▲ 1.59% NATU3 5.17 — 0.00% BRKM5 3.20 — 0.00% RANI3 8.53 ▲ 0.83% CSNA3 4.41 — 0.00%
since 2009
Sunday, November 8, 2026

Brazil Covid-19

First case of double facial paralysis documented after first and second Pfizer vaccine doses

By · · 3 min read

RIO DE JANEIRO, BRAZIL – The 61-year-old patient experienced two facial palsies, one after the first and the other after the second dose of the Pfizer-BioNTech vaccine which may suggest that Bell’s palsy of facial nerves of unknown cause “is related” to this vaccine, according to the study’s authors.

This is the first case documented in medical literature of two unilateral facial nerve palsies, in which the muscles on one side of the face are weakened or paralyzed, occurring shortly after each dose of the Covid-19 vaccine. The article was published in BMJ Case Reports scientific journal.

Read also: Deaths occurring after Covid-19 vaccinations have become hot topic in the U.S.

Free daily brief — no card needed
Get every Brazil story in one morning email
We build you a personalized brief around the topics you follow — free for 7 days. Love it? Your first month after that is US$1.

According to the authors, “the occurrence of such events immediately after each vaccine dose strongly suggests that Bell’s palsy was associated with the Pfizer-BioNTech vaccine, although a causal relationship cannot be established.”

In a press release, the publication recalls that in the initial clinical trials of the three main Covid-19 vaccines, Pfizer-BioNTech, Moderna and Oxford/AstraZeneca, 10 events of unilateral facial nerve palsy were reported, and there have been subsequent case reports.

1
Cases of Bell’s palsy are generally believed to be related to inflammation and swelling of the facial nerve due to fluid accumulation (edema) caused by a virus.
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

This “case study” describes a 61-year-old Caucasian male with no history of facial nerve palsy who experienced an event on the right side of the face 5 hours after being administered the first dose of the Pfizer-BioNTech vaccine.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Paraguay's Senate ousts its president after a bank failure”

Free. We send a confirmation link first — nothing arrives until you click it. Unsubscribe with one click in any edition. If you stop opening us for 30 days we stop sending by ourselves, as we assume the interest is no longer there. See our privacy policy. We never share your email.

And a more severe event (with difficulty swallowing and inability to fully close his left eye, among other symptoms) on the left side of the face 2 days after the second dose.

The patient had a high body mass index, high blood pressure, high cholesterol, and type 2 diabetes. The authors report that his symptoms have greatly improved and he is has returned to near normal.

Cases of Bell’s palsy are generally believed to be related to inflammation and swelling of the facial nerve due to fluid accumulation (edema) caused by a virus.

Risk factors include diabetes, obesity, hypertension, pregnancy, pre-eclampsia and upper respiratory tract diseases.

According to the statement, an increased incidence of Bell’s palsy has also been observed after the administration of other influenza and meningococcal vaccines, although a causal relationship has not been established.

Study finds low risk

Covid-19 patients are 7 times more likely to suffer facial palsy than people vaccinated against the coronavirus, a study has found. The research published in JAMA scientific journal pointed out that Bell’s palsy, a nerve condition that causes a patient to experience muscle weakness in the middle of the face, is an uncommon side effect of vaccines but it is in fact more common among patients who contract the coronavirus.

The findings emerged from a study by University Hospitals Cleveland Medical Center and Case Western Reserve University School of Medicine researchers, who found that coronavirus patients were 7 times more likely to develop facial paralysis compared with those who had been vaccinated against the disease.

Among the 37,000 immunized individuals who took part in the study, only 8 cases of Bell’s palsy were reported, an incidence of 19 cases per 100,000 vaccinated subjects, compared with an incidence of 82 per 100,000 for coronavirus patients.

While physicians and vaccine manufacturers will continue to carefully monitor vaccine side effects, the research team stressed that the findings suggest that Bell’s palsy should be an additional reason to be vaccinated, rather than a side effect to be feared.

Source: Infobae

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.